SCHEMBL6468413

SCHEMBL6468413

CCc1ccnc(F)c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10532368 0.92 LOXL2 (0.55) —
SCHEMBL10238963 0.83 LOXL2 (0.59) —
SCHEMBL12893452 0.79 LOXL2 (0.55) —
SCHEMBL22241346 0.78 LOXL2 (0.44) —
SCHEMBL1211655 0.78 LOXL2 (0.53) —
SCHEMBL1348600 0.77 — —
SCHEMBL2642497 0.77 — —
SCHEMBL116309 0.77 — —
SCHEMBL7413054 0.77 — —
SCHEMBL29893902 0.77 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 70 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118084724-A Method for preparing aryl nitrile by copper-catalyzed oxidation and cleavage of alkyl-substituted aromatic ring and aromatic heterocyclic carbon-carbon bond 中国科学院大连化学物理研究所 2024-05-28 — — CN disclosed
US-20230295131-A1 INHIBITORS OF RHO-ASSOCIATED COILED-COIL KINASE ANGION BIOMEDICA CORP. 2023-09-21 — — US disclosed
US-11737463-B2 Pyridine and pyrazine compounds BASF SE (DE) 2023-08-29 — — US disclosed
US-20230257362-A1 TRIAZOLONE COMPOUND MEDSHINE DISCOVERY INC. (CN) 2023-08-17 — — US disclosed
EP-4223739-A1 3,6-BIS(CYANOMETHYLIDENE)CYCLOHEXA-1,4-DIENE COMPOUNDS AND THEIR USE IN ORGANIC ELECTRONIC DEVICES Novaled GmbH (DE) 2023-08-09 — — EP disclosed
US-20230203010-A1 BICYCLIC AMINE CDK12 INHIBITORS INCYTE CORPORATION 2023-06-29 — — US disclosed
US-20230142119-A1 TETRACYCLIC COMPOUND CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2023-05-11 — — US disclosed
US-11584738-B2 LPA receptor antagonists and uses thereof GILEAD SCIENCES, INC. (US) 2023-02-21 — — US disclosed
US-11566001-B2 Hepatitis B capsid assembly modulators VenatoRx Pharmaceuticals, Inc. (US) 2023-01-31 — — US disclosed
US-20230025510-A1 BIARYL ETHER-TYPE QUINAZOLINE DERIVATIVES DAIICHI SANKYO COMPANY, LIMITED (JP) 2023-01-26 — — US disclosed
US-20080293718-A1 Novel 2-Amino-Imidazole-4-One Compounds and Their Use in the Manufacture of a Medicament to Be Used in the Treatment of Cognitive Impairment, Alzheimer's Disease, Neurodegeneration and Dementia ASTRAZENECA AB (SE) 2008-11-27 — — US disclosed
US-20070129367-A1 Pyridine derivatives as cb2 receptor modulators GLAXO GROUP LIMITED (GB) 2007-06-07 — — US disclosed
US-20070129367-A1 Pyridine derivatives as cb2 receptor modulators GLAXO GROUP LIMITED (GB) 2007-06-07 — — US disclosed
EP-0799207-B1 PROCESS FOR THE PREPARATION OF FLUORINATED HETEROCYCLIC COMPOUNDS F2 CHEMICALS LIMITED (GB) 1999-06-09 — — EP disclosed
US-5859255-A Process for the preparation of fluorinated heterocyclic compounds F2 CHEMICALS LTD. (GB) 1999-01-12 — — US disclosed
CN-1170406-A Preparation of fluorinated heterocyclic compounds F2 CHEMICAL PRODUCTS LTD (GB) 1998-01-14 — — CN disclosed
EP-0799207-A1 PROCESS FOR THE PREPARATION OF FLUORINATED HETEROCYCLIC COMPOUNDS BNFL FLUOROCHEMICALS LTD. (GB) 1997-10-08 — — EP disclosed
WO-1996019456-A1 PROCESS FOR THE PREPARATION OF FLUORINATED HETEROCYCLIC COMPOUNDS BNFL FLUOROCHEMICALS LTD. (GB) 1996-06-27 — — WO disclosed
WO-1996003379-A1 THE ALKOXYLATION OF HETEROCYCLIC COMPOUNDS IN THE PRESENCE OF FLUORINE BNFL FLUOROCHEMICALS LTD. (GB) 1996-02-08 — — WO disclosed
US-4786733-A CONTACTING WITH FLUORINE GAS ALLIED-SIGNAL INC. (US) 1988-11-22 — — US disclosed
Send feedback